225Ac-DGUL

N/A

Report date: 2025/11/20 16:04:30

NME

Base Information

Drug Name225Ac-DGUL

Drug Alias Name225Ac-DGUL225Ac DGUL

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellbion Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCellbion Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A